Answers are grounded in this paper and cite their sources.
Conceptual note explores historical connections in tumor biology and matrix safety assessment, suggesting new frameworks.
This conceptual note documents a historical methodological bridge from earlier work on the cathepsin–cystatin axis in tumor biology toward later regime-based approaches in matrix-toxicology and cosmetic safety assessment. The manuscript does not propose a new cancer model, clinical interpretation, diagnostic approach, or therapeutic strategy. Instead, it interprets cathepsin–cystatin balance as a historical example of structural reasoning based on balance, context, spatial coupling, damping capacity, and regime transition. Within this perspective, BARE — Balance- and Adaptive-Regime Evaluation — is introduced as a heuristic framework for regime recognition and adaptive exposure control in complex systems. The note positions the earlier biological research phase as a completed scientific chapter and connects it methodologically to current work on complex matrices, structured uncertainty, and cosmetic risk assessment.
No takes yet. Share an insight, caveat, or question.
Bernd Werle (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: